Cargando…
Evaluation of miRNA 223/125a and COBLL1 Expressions and ROR-1 Levels as Reliable Markers in B- chronic Lymphocytic Leukemia
BACKGROUND: miRNA 223 /125a and Cordon-bleu Protein Like 1 (COBLL1) are novel biomarkers that can predict prognosis and guide treatment decisions in patients with chronic lymphocytic leukemia (CLL). Also, there is a growing interest in CLL monitoring based on flow cytometry of receptor tyrosine kina...
Autores principales: | Hussein, Samia, Abdelazem, Abdallah S., Abdelmoneem, Shimaa, Abdelnabi, AL-Shabrawy M., Khamis, Tarek, Obaya, Ahmed Ali, Ebian, Huda F |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
West Asia Organization for Cancer Prevention
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9741902/ https://www.ncbi.nlm.nih.gov/pubmed/36037128 http://dx.doi.org/10.31557/APJCP.2022.23.8.2735 |
Ejemplares similares
-
Peripheral blood CD26 positive leukemic stem cells as a possible diagnostic and prognostic marker in chronic myeloid leukemia
por: Ebian, Huda F, et al.
Publicado: (2022) -
Expression of COBLL1 encoding novel ROR1 binding partner is robust predictor of survival in chronic lymphocytic leukemia
por: Plešingerová, Hana, et al.
Publicado: (2018) -
Cobll1: A new player in CML
por: Kim, Hongtae, et al.
Publicado: (2017) -
COBLL1 and IRS1 Gene Polymorphisms and Placental Expression in Women with Gestational Diabetes
por: Ustianowski, Przemyslaw, et al.
Publicado: (2022) -
Molecular Analysis of Alternative Transcripts of the Equine Cordon-Bleu WH2 Repeat Protein-Like 1 (COBLL1) Gene
por: Park, Jeong-Woong, et al.
Publicado: (2015)